Connexin (CX) proteins participate in growth, differentiation, and tissue remodeling. Relaxin-stimulated reproductive tissue growth and remodeling may be facilitated by enhanced intracellular communication. This study was an examination of the effects of relaxin in vivo on expression of CX-26, CX-32, and CX-43 in the cervix and uterus of prepubertal pigs. In addition, expression of these proteins was monitored in the sow uterus during pregnancy. Relaxin was administered to prepubertal gilts every 6 h for 54 h. CX expression was characterized by immunoblotting and localized by immunofluorescence. Significant increases in all three CXs were observed in the cervix following relaxin treatment (P Ͻ 0.05). Uterine CX proteins were also significantly higher (P Ͻ 0.05) in relaxin-treated animals compared to controls. The CX protein level in relaxin-treated animals was similar to that observed during the second half of pregnancy, but below levels found in mature, nonpregnant sows. This is the first evidence for specific CX expression in the porcine cervix, and the first study to show that relaxin increases the expression of CX proteins in the porcine uterus and cervix. The data show that CX proteins are differentially regulated in the uterus of the pig during pregnancy. These data support a role for CX-mediated communication during relaxin-induced reproductive tissue growth and remodeling.
INTRODUCTION
Relaxin changes the mechanical properties of reproductive tissue, stimulating the growth and remodeling of the porcine uterus and cervix [1, 2] . However, the means by which relaxin promotes reproductive tissue growth and remodeling are not fully understood. Changes in uterine and cervical connective tissue matrix composition [3] and proteolytic enzyme profile [4, 5] are associated with relaxininduced growth. In addition, relaxin's uterotropic effects in vivo involve changes in the uterine insulin-like growth factor system [6] . It has also been reported that relaxin modulates cell-cell communication in uterine myometrial [7] and endometrial stromal cells [8] in vitro. Given the importance of cell-cell communication in regulating tissue growth [9, 10] , the possibility that relaxin facilitates growth by enhancing intracellular communication should be considered.
Gap junctions are involved in the regulation of cellular proliferation and tissue homeostasis. As mediators of intercellular communication, they permit the exchange of nutrients, ions, and small regulatory proteins between adjoining cells [5, 10] . Gap junction proteins belong to an evolutionarily conserved, multigene family of channel-forming proteins called connexins (CXs), which assemble as hexameric hemichannels (connexons) between the membranes of adjacent cells [9, 11] . These CXs form a family of at least 13 proteins that are named on the basis of their molecular size [12] . In the uterus, connexin-26 (CX-26) and connexin-32 (CX-32) are the major gap junction proteins in the endometrium [13, 14] , while CX-43 is the predominant CX in myometrial smooth muscle cells [15, 16] .
Tissue-specific regulation of CX expression by steroid hormones has been demonstrated in the uterus on the basis of studies of pregnant animals [16] [17] [18] [19] . Progesterone suppresses myometrial/endometrial CX-26 and CX-43 during pregnancy, while estrogen induces CX-43 expression in the myometrium. In addition to steroid hormones, growth factors that activate myometrial protein kinase pathways have been implicated in the regulation of myometrial CX-43 gene expression [20] . Relaxin activates uterine protein kinases [21, 22] and thus may contribute to changes in CX protein expression and/or activity. In contrast, factors regulating cervical gap junction-mediated, cell-cell coupling have yet to be reported. While gap junctions between muscle cells of the human uterine cervix have been reported [23] , expression of specific CX proteins in cervical tissues has not been characterized. Additionally, whether gap junction expression is altered during the extensive, hormonedriven remodeling of the cervix during pregnancy has not been investigated.
The objective of these studies was to characterize CX protein expression during uterine and cervical growth and remodeling in the pig. Changes in CX expression were studied in prepubertal gilts treated with relaxin to induce uterine and cervical growth in the absence of steroids. In addition, pregnant sows were utilized to characterize CX expression during physiological uterine growth and remodeling.
MATERIALS AND METHODS

Materials
Purified porcine relaxin (CM-A fraction; 3000 U/mg) was prepared at the Department of Biomedical Sciences (University of Guelph, ON, Canada) by extraction and purification from ovaries of pregnant sows [24] . Purity was confirmed by SDS-PAGE, which revealed a single band at approximately 6.2 kDa. The biological activity of the relaxin preparation was ascertained by inhibition of spontaneous uterine motility in vitro [25] , and immunoreactivity was verified by RIA [26] 
Animals
Prepubertal (ϳ115 days old) Yorkshire-Landrace gilts (Swine Unit of the New Jersey Agricultural Experiment Station, Rutgers University, New Brunswick, NJ) were injected i.m. with porcine relaxin (0.5 mg/0.5 ml saline; n ϭ 4) or saline (0.5 ml; n ϭ 5) every 6 h for 54 h [2] . Uterine and cervical tissues were collected and processed as described by Wang-Lee et al. [4] . Briefly, this involved cutting 1-cm segments from the uterus and the uterine, center, and vaginal portions of the cervix. Additionally, skeletal muscle, which is fused to form a functional syncytium and does not contain gap junctions [12] , was collected and frozen in liquid nitrogen for use as a negative control in immunoblot analysis. The marked trophic effects of relaxin on the uterus and cervix, and the systemic and local concentrations of relaxin achieved after in vivo relaxin administration in this animal model, have been reported [2, 4, 6] . The prepubertal status of the gilts was confirmed by the absence of estradiol-17␤ in the plasma and uterine flushes of all animals before and after the treatment regimen [6] . In addition, follicular estradiol levels from control and relaxin-treated gilts (1.18 Ϯ 0.42 and 0.51 Ϯ 0.10 ng/ml, respectively) [6] were an order of magnitude lower than in cyclic animals (10-500 ng/ml) [27] .
In other experiments, multiparous Duroc sows that exhibited at least two estrous cycles averaging 21 days were checked for estrus in the presence of a boar, and the first day of estrus was designated Day 0 of the cycle. Pregnant sows were obtained by mating animals on the first day of estrus, which was then designated Day 0 of pregnancy. Uteri were collected from pregnant sows on Days 40, 90, and 110 of pregnancy [28] . At the time of tissue collection, sows were stunned and exsanguinated. In addition, uteri from nonpregnant mature pigs were obtained from a local abattoir. All tissues were immediately frozen in liquid nitrogen and stored at Ϫ80ЊC until use. The animal experimentation procedures described here were reviewed and approved by the Rutgers University Animal Care Advisory Committee.
Progesterone RIA
Progesterone was measured in plasma and uterine flushes after extraction with petroleum ether [29] . 4-Pregnen-3,20-dione antibody and 1,2,6,7-3 H progesterone were obtained from Steraloids (Wilton, NH) and Amersham, respectively. Intra-and interassay coefficients of variation for the assay were 3.4 Ϯ 1.4% and 11.1 Ϯ 3.8%, respectively, and assay sensitivity was 0.4 ng/ml.
Immunoblotting
Protein was extracted from tissue samples as described previously [30] . Briefly, tissues were homogenized in boiling lysis buffer, sonicated to reduce viscosity, and centrifuged to remove insoluble material. Protein samples (15 g) were resolved on 10% Bis-Tris-HCl-buffered polyacrylamide electrophoresis gels (Novex, San Diego, CA) under reducing conditions and transferred onto polyvinylidene difluoride membranes (Millipore, Bedford, MA). Membranes were blocked in 5% BSA in Tris-buffered saline (TBST); they were then incubated with anti-CX-26, CX-32, or CX-43 antibody (1 g/ml) in TBST/1% BSA overnight at 4ЊC. After primary antibody incubation, membranes were washed with TBST and incubated with horseradish peroxidase-conjugated goat anti-mouse IgG (1:5000 in TBST/5% nonfat dry milk) for 1 h at room temperature (RT). After washing in TBST, membrane-bound antibodies were detected by chemiluminescence. Antiserum specificity was confirmed in separate immunoblot experiments by absorption of each CX antibody (1 g/ml) with excess CXspecific peptide (10 g/ml) for 10 min at RT prior to use. In these experiments, membranes were blocked in TBST/ 5% nonfat dry milk (2 h at RT) and then incubated with the antibody/peptide solutions (1 h at RT).
Immunohistochemistry
Frozen cervical tissue sections were hydrated in PBS (0.015 M) for 5 min at RT prior to immunostaining. Paraffin-embedded uteri were processed for immunohistochemistry as described in Lenhart et al. [30] , with modifications. Tissue sections were incubated in 0.1% buffered trypsin (porcine pancreas type II) for 10 min at RT to unmask antigens. Cervical and uterine tissues were blocked in 3% BSA, 3% NGS, and 3% NSS in PBS (BGS-PBS) for 1 h at RT; they were then incubated overnight at 4ЊC with either CX-26, CX-32, or CX-43 antibodies (4 g/ml in PBS). Normal mouse IgG served as the negative control for all antibodies. Sections were rinsed in PBS (5 times, 3 min each) and then incubated with FITC-conjugated goat anti-mouse IgG (1:25 in BGS-PBS) for 1 h at RT in a lighttight, humidified box. Tissues were washed in PBS (5 times, 3 min each) and then mounted in an antifade reagent (Slowfade; Molecular Probes, Eugene, OR). Fluorescent staining was viewed using a Zeiss Axioskop (Carl Zeiss, Thornwood, NY) microscope equipped with filters for fluorescence microscopy and photographed using T-MAX 400 film. In addition, immunolabeled sections were examined by confocal laser scanning microscopy using a Zeiss Laser Scanning Microscope 410 Invert, equipped with an argon/ krypton laser and fitted with the appropriate filter blocks for the detection of fluorescein. Images were taken using consistent brightness and contrast settings and a line (8) averaging function. Nearby sections were stained with hematoxylin and eosin to confirm uterine and cervical histology.
Densitometry and Statistical Analysis
CX proteins were quantified in the immunoblots by scanning densitometry (Sigma Gel; SPSS, Chicago, IL). Data are expressed as the mean Ϯ SEM of samples from pregnant and nonpregnant sows and control and relaxintreated gilts using at least 3 animals per group. Data were examined by ANOVA and tested for differences by Fisher's least significant difference. A value of P Ͻ 0.05 was accepted as significant.
RESULTS
Progesterone RIA
Progesterone was monitored to determine whether systemic or local progesterone was contributing to the effects Representative micrographs of cervices from control (A) and relaxin-treated (B) gilts, stained with hematoxylin and eosin to illustrate tissue composition. C-H) Cervical CX protein in tissue sections from control and relaxin-treated animals, incubated with monoclonal CX-specific antibodies (4 g/ml) and visualized using an FITC detection system. Cervical epithelium (E) with borders indicated by white line (ı---ı), lumen (L), stroma (S). C, D) CX-26 protein was detected in the epithelium bordering the lumen of control (C) and relaxin-treated animals (D), while CX-32 protein was more evident in the epithelium adjacent to the stroma (E and F). Immunoreactive CX-43 was absent in epithelial cells of the cervix; however, intense CX-43 labeling was observed in the cervical stroma of control (G) and relaxintreated (H) gilts. Bar ϭ 100 m.
observed. Prepubertal animals were used so that the effect of relaxin on CX expression could be analyzed independently of the effects of systemic and/or local steroids. Progesterone was undetectable in the plasma and uterine flushes of all animals before and after the treatment regimen.
Effect of Relaxin on CX-26, CX-32, and CX-43 Protein Expression in the Cervix
Maximal growth and remodeling activity in the uterine and vaginal portions of the cervix takes place at different times during pregnancy [31] . When tissue homogenates from uterine (UC), center (CC), and vaginal (VC) portions were analyzed, immunoreactive bands corresponding to CX-26 (ϳ28 kDa), CX-32 (ϳ31 kDa), and CX-43 (ϳ43 kDa) were observed throughout the cervix of control and relaxin-treated prepubertal gilts. Relaxin administration significantly (P Ͻ 0.05) increased cervical expression of all three CX proteins examined in comparison to the control values (Fig. 1, A-C) . While no difference in CX-26 or CX-32 protein was observed between the UC, CC, and VC, CX-43 protein expression was greater in the VC of relaxintreated animals when compared to the UC (P Ͻ 0.05). No immunoreactivity was detected in skeletal muscle samples, even with longer exposure (data not shown).
Localization of CX-26, CX-32, and CX-43 in the Cervix of Control and Relaxin-Treated Prepubertal Gilts Figure 2 , A and B, shows representative brightfield micrographs of the center cervix from control ( Fig. 2A) and relaxin-treated (Fig. 2B ) prepubertal gilts. The fluorescence micrographs of the cervix (Fig. 2 , C-H) illustrate areas similar to those shown in brightfield. In cervices from prepubertal, relaxin-treated animals, CX-26 ( Fig. 2D) as well as CX-32 ( Fig. 2F ) immunofluorescence was associated with the luminal epithelial cell layer. Specifically, CX-26 immunofluorescence was more prominent in epithelial cells (E) bordering the lumen (L), while immunoreactive CX-32 was more concentrated in epithelial cells adjacent to the stroma. In prepubertal controls, a similar pattern of CX-26 and CX-32 staining was observed (Fig. 2, C and E) ; however, expression was more intense in the cervices of relaxin-treated animals. On the other hand, CX-43 immunoreactivity was not evident in the luminal epithelium of either control or relaxin-treated prepubertal gilts. Instead, intense, punctate CX-43 immunofluorescence was observed in the cervical stroma of both groups (Fig. 2, G and H) .
Effect of Relaxin and Pregnancy on CX-26, CX-32, and CX-43 Protein Expression in the Porcine Uterus
Uterine CX-26 expression throughout pregnancy (Days 40, 90, and 110) was similar to expression in prepubertal animals (Fig. 3A) . Uterine CX-26 immunoreactivity in prepubertal pigs was significantly higher in relaxin-treated animals than in prepubertal controls and pregnant pigs at Day 40 and Day 90 (P Ͻ 0.05). In contrast, uterine CX-26 expression in Day 110 pregnant pigs and relaxin-treated prepubertal animals was similar. CX-26 protein in the uteri of mature, nonpregnant sows was significantly greater (P Ͻ 0.01) than in pregnant, prepubertal, or relaxin-treated prepubertal gilts. Uteri from pregnant animals at Day 40 and Day 90 had significantly higher (P Ͻ 0.05) amounts of CX-32 than those of animals at Day 110 (Fig. 3B) . By Day 110 of pregnancy, expression of CX-32 protein was attenuated to levels similar to those in control prepubertal animals. Relaxin administration enhanced uterine CX-32 pro- C-H) Uterine CX protein in tissue sections from control and relaxin-treated prepubertal gilts, incubated with monoclonal CX-specific antibodies (4 g/ml) and visualized using an FITC detection system. Endometrial gland (EG), blood vessel (BV), stroma (S), myometrium (M). C, D) CX-32 protein was lightly scattered in the endometrium of control gilts (C) and evident in the epithelium of the endometrial glands of relaxin-treated animals (D). E, F) CX-43 labeling in the endometrium was found predominantly in stromal fibroblasts of control animals (E) and more intensely ᭣ associated with the stromal blood vessels of gilts after relaxin administration (F). G, H) Myometrial CX-26 immunostaining is representative of CX protein abundance in uterine myocytes before (G) and after (H) exposure to relaxin. Bar ϭ 100 m. tein expression in prepubertal pigs when compared to controls (P Ͻ 0.05) and pregnant pigs at all three time points analyzed (P Ͻ 0.01). As observed for CX-26, immunoreactive CX-32 protein was significantly higher (P Ͻ 0.05) in the uteri of nonpregnant mature sows than in pregnant, prepubertal, or relaxin-treated prepubertal animals. While uterine CX-26 and CX-32 proteins appeared as broad, immunoreactive bands at 26 and 32 kDa, respectively (Fig. 3,  A and B) , uterine CX-43 expression was characterized by multiple immunoreactive proteins, ranging in size from 43 to 47 kDa (Fig. 3C) . The 43-kDa-immunoreactive band was observed in uterine tissue from all animals, regardless of treatment. In contrast, the higher molecular size bands (see * in Fig. 3C ), which corresponded to the phosphorylation pattern of CX-43 observed in other tissues [32] , were detected in all but the immature control animals. Total CX-43 protein expression was quantified by adding densitometric values for all bands in a given lane. The pattern of CX-43 immunoreactivity in porcine uteri (Fig. 3C ) was comparable to that observed for CX-26 (Fig. 3A) , in that uterine CX-43 expression in pregnant sows and immature gilts was similar. Likewise, treatment of prepubertal gilts with relaxin resulted in a significant increase (P Ͻ 0.05) in immunoreactive CX-43 when compared with that in controls. In addition, CX-43 expression in uteri from nonpregnant sows was significantly higher (P Ͻ 0.05) than in any other experimental group.
Localization of CX-26, CX-32, and CX-43 in the Uterus of Control and Relaxin-Treated Prepubertal Gilts
The brightfield micrographs shown in Figure 4 , A and B, are representative of the uterine tissues in which CX proteins were localized after relaxin treatment of prepubertal pigs. The confocal fluorescence micrographs of the endometrium (Fig. 4, C-F) illustrate areas similar to that shown in the brightfield view (Fig. 4A) . Immunoreactive CX-32 was scarce in the endometrium of control animals (Fig. 4C) , while punctate endometrial CX-32 was associated with the epithelial lining of the endometrial glands and surrounding stromal tissue of relaxin-treated gilts (Fig. 4D) . Scattered CX-43-immunopositive plaques were identified in the endometrial stroma of control and relaxin-treated animals. In addition, intense CX-43 immunoreactivity was observed in association with the endothelial layer of the blood vessels in the endometrial stroma (Fig. 4, E and F) . There was little or no evidence for specific CX-26 immunolabeling in the endometrium of control or relaxin-treated prepubertal gilts (data not shown). Punctate myometrial CX-26, CX-32, and CX-43 immunofluorescence was observed in both control and relaxin-treated prepubertal gilts. While the images in Figure 4 , G and H, illustrate myometrial CX-26 immunostaining, they are representative of the low-level staining observed for all three CXs in control and relaxintreated pigs. The punctate areas of CX-26 immunoreactivity in the myometrial micrographs (Fig. 4, G-H) were chosen at a point where the endometrial stroma (S) meets the myometrium (M) in order to demonstrate positive myometrial CX immunofluorescence alongside areas of stromal tissue that did not cross-react with the antibodies. Endometrial and myometrial CX protein expression was low, even after relaxin administration, and when compared to CX immunofluorescence in the cervix (Fig. 2, C-H) . No specific immunolabeling was detected when tissues were incubated with control mouse immunoglobulin (data not shown).
DISCUSSION
Hall and colleagues [2, 33] first reported relaxin-mediated growth and remodeling of the prepubertal pig uterus and cervix. In the present study, relaxin's growth-promoting effect, confirmed by studies in our laboratory [4, 6] , was associated with significant changes in the expression of gap junction proteins CX-26, CX-32, and CX-43 in both the uterus and cervix of the prepubertal gilt. Spatial and temporal regulation of CX protein expression during pregnancy in the mammalian uterus has been documented [14, 16, 34] and has been correlated with changes in estrogen and progesterone levels [19, 35, 36] . The data presented here support and extend those observations by demonstrating that relaxin enhances expression of these proteins in the absence of endogenous steroids. In addition, we report here for the first time that CX-26, -32, and -43 gap junction proteins are expressed in the porcine cervix and that relaxin increases the expression of these CXs in the cervix of the prepubertal pig. Moreover, we demonstrate that cervical CX-26, -32, and -43 proteins in the relaxin-treated prepubertal gilt are restricted to specific tissue compartments.
Relaxin plays a major role in promoting growth and softening of the cervix during late pregnancy in many mammalian species [37] . While high-affinity relaxin-binding sites have been identified in cervical tissues of the pig [38] and rat [39] , the mechanism by which relaxin binding is translated into cervical remodeling is not fully elucidated. Our data establish that porcine cervical gap junctions are composed of at least three different CX proteins-CX-26, -32, and -43-and that one of the actions of relaxin on the porcine cervix is to increase the expression of these three proteins. The tissue-specific expression of CX isotypes we observed in the cervix, with CX-26 and CX-32 localized in luminal epithelial cells and CX-43 in stromal and muscle tissue, is comparable to their distribution in the uterus under the influence of estrogen [16, 23] . However, the physiological significance of an increase in these cervical CX proteins in response to relaxin is unclear. In other tissues, alterations in the temporal and spatial patterns of CX expression occur during development and adaptive physiological processes [40, 41] . The relaxin-mediated transformation of the cervix involves extensive remodeling of the cervical connective tissue matrix [33, 42, 43] and an increase in connective tissue enzyme activity [4, 44] . In addition, relaxin stimulates cervical secretory activity [44, 45] and enhances luminal epithelial cell proliferation [46] . Thus, relaxin may enhance CX protein expression in order to coordinate cervical connective tissue remodeling. Our data also suggest that, by increasing cervical CX protein expression, relaxin may mediate cell-cell communication between endothelial cells and the surrounding stroma and smooth muscle, thereby inducing proliferation of quiescent endothelial cells in the cervix. A potential role for relaxin in the proliferation of cervical endothelial cells is supported by several lines of evidence. First of all, endothelial cells of the cervix contain relaxin-binding sites in both the rat and the pig [38, 39] . Secondly, relaxin has been reported to increase arterial cross-sectional area of the porcine cervix [3] . Finally, cell proliferation in the cervical endothelium of the rat was enhanced following relaxin treatment [46] . Likewise in the uterus, relaxin may facilitate growth of endothelial cells through gap junction communication, as CX-43 immunostaining is associated with blood vessels and relaxin significantly increases uterine CX-43 protein expression (Fig. 3C ). This is supported by histological studies showing that relaxin significantly enhances uterine vascularization [47] , and endothelial cell proliferation [48] in a manner similar to that reported for the cervix.
While we found a relaxin-induced increase in cervical gap junction proteins, relatively little information is available concerning steroidal control of cervical gap junction expression. In contrast to the situation for gap junction expression in the myometrium, there is no correlation between cervical gap junction density and the estrogen/progesterone ratio in women [23] . In addition, no increase in the number of cervical gap junctions was observed immediately before or during labor, as is seen in the myometrium [23] , suggesting that formation of myometrial and cervical gap junctions does not occur simultaneously during pregnancy. The absence of a relationship between changing steroid concentrations and cervical gap junction formation implies that other factors, such as relaxin, may be involved in the regulation of cervical gap junction communication. In this study, we present evidence to support the hypothesis that relaxin may coordinate cervical remodeling via enhanced CX protein expression and that this effect is independent of ovarian steroids.
The importance of gap junctional communication in facilitating implantation [13, 14, 34] and controlling myometrial contraction at the time of parturition is well documented [19, 35, 49] . However, the significance of cell-cell communication during uterine growth, which occurs throughout the course of pregnancy, is less clear. Channels composed of CX-43 are important for electrical coupling between muscle fibers, such as in the myometrium [50] ; CX-26 channels are found in nonexcitable cell types, such as uterine epithelial cells [14, 35] , where they are thought to be important contributors to metabolic coupling. Growth factors such as relaxin, which raise cAMP levels [51] and activate protein kinase pathways [21, 22] , can affect gap junction communication [7] and have been implicated in the regulation of CX expression in uterine myocytes [20] . Our immunoblotting data demonstrate an increase in uterine CX protein expression in response to relaxin. While the functional significance of this increase in CX protein is unknown, given relaxin's established uterotropic effects [1, 2] , these findings suggest that relaxin may enhance metabolic coupling between cells in the porcine uterus and contribute to the exchange of growth-promoting regulatory molecules. Furthermore, the immunolocalization data presented here are consistent with the observation that the growth-promoting effects of relaxin in the pig are not dependent on prior exposure to estrogen [2] . These localization studies allowed us to determine the cell types in the porcine uterus that expressed CX-26, -32, and -43. However, the immunostaining was not sensitive enough to unequivocally demonstrate differences in uterine CX expression due to relaxin treatment in specific cell types, as was the case in porcine cervical tissues. The intensity of uterine CX immunostaining in response to relaxin (Fig. 4) could best be described as intermediate between the high level of CX expression observed after exposure to estrogen and the significant attenuation of CX expression seen in response to progesterone [16, 17, 23, 52] . Thus, we propose that relaxin may act in concert with estrogen and progesterone to regulate CX-mediated communication in the uterus.
In the pig, circulating progesterone is elevated throughout gestation; it then declines precipitously at the time of parturition [53] . In contrast, plasma estrogens are undetectable until Day 80, then rise steadily in later gestation, with peak levels achieved just before parturition [53] . This results in an increase in the estrogen/progesterone ratio in the sow as pregnancy progresses. On the other hand, relaxin is secreted throughout the 114-day gestation period in the pig and is detectable within 1 wk of conception. Systemic relaxin increases to about 10 ng/ml by Day 110 of pregnancy, followed by a surge 2 days prior to parturition [54] . Thus, the observation that uterine CX expression was not significantly different in sows between Day 40 and Day 110 of pregnancy was unexpected, given the impact of estrogen treatment on CX expression in other species [16, 19, 35] and the effects of relaxin reported here. These data suggest that in pregnant sows, progesterone domination of the uterus through Day 110 of gestation is sufficient to inhibit the positive impact of circulating estrogens and relaxin on CX expression.
In conclusion, these studies demonstrate that CX-26, CX-32, and CX-43 are expressed in the cervix of the prepubertal pig in a spatially distinct fashion and that relaxin enhances the expression of cervical gap junction proteins. While we show that relaxin also enhances uterine expression of CX-26, CX-32, and CX-43 gap junction proteins, we found that cervical CX protein expression in response to relaxin was greater than that of the uterus. Our data revealed that immunoreactive CX protein expression during relaxin-mediated uterine growth approached levels observed toward the end of pregnancy, even in the absence of circulating steroids. Given relaxin's ability to promote growth and remodeling in the reproductive tract, we propose that relaxin increases cell-cell communication between the diverse cellular components of the porcine cervix and uterus, thus coordinating cervical growth and uterine accommodation in the pig.
